Public interest in traumatic brain injury has grown considerably in recent years, with increased awareness of the scale of its burden on public health, especially in those involved in contact sports or in the military. Recent funding into the neurodegenerative disease, chronic traumatic encephalopathy (CTE) in particular, from the US National Football League and Department of Defence has garnered much media attention and highlighted the dangers of repetitive brain trauma.
In light of this growing focus, Alzheimer’s Research & Therapy launched a special series on Traumatic Brain Injury, with Robert Stern from Boston University, USA, as Series Editor. In an accompanying podcast addressing what we currently know about CTE and the most important questions in the field, Biome spoke to Stern and three other experts who contributed to the series; Charles Bernick from the Cleveland Clinic, USA, Thor Stein from Boston University, USA, and Alexander Lin from Brigham and Women’s Hospital, USA.
Here, they discuss how our understanding of CTE and its clinical symptoms has developed, what insights recent studies have revealed and the wide ranging implications research in this area may have for those exposed to repetitive head trauma. Read the transcript of this podcast here.
“This is going to be a tremendously exciting decade. We’re now ready to fully take advantage of existing and future technical and neuroscientific developments because of everything that’s happened in the last few years in the study of CTE. There’s now funding, there’s now interest, there’s now the beginnings of an understanding of this disease.”
Robert Stern, Boston University
The Traumatic Brain Injury series brings together basic scientists, clinical scientists and epidemiologists from a variety of fields, all with the aim of improving the current understanding of the long-term effects of repetitive brain trauma and in particular the development of CTE. Contributions range from the potential epidemiology of CTE in former NFL players and boxers as well as the neuropathology of the disease, to insights from magnetic resonance spectroscopy and the development of approaches for clinical diagnosis.
Interviews conducted by Kathryn Smith, in-house Editor for Alzheimer’s Research & Therapy.
The complete list of series articles: